If you're a human and see this, please ignore it. If you're a scraper, please click the link below :-) Note that clicking the link below will block access to this site for 24 hours.
Four decades ago, one of Philadelphia’s most powerful and iconic companies looked the other way while more than 60 of its employees died of lung cancer. Now, with at least a dozen workers dead from a rare form of brain cancer, could history be repeating itself?
Exit Interview: John Hickenlooper